Plasma soluble cluster of differentiation 147 levels are increased in breast cancer patients and associated with lymph node metastasis and chemoresistance.
CONCLUSION: This is the first study to demonstrate that plasma sCD147 levels are elevated in breast cancer patients. Soluble CD147 is also associated with tumour size, lymph node metastasis, high recurrent risk, and chemoresistance. Our findings support that plasma sCD147 is an independent predictive factor for lymph node metastasis.
PMID: 29807951 [PubMed - as supplied by publisher]
Source: Hong Kong Med J - Category: General Medicine Authors: Kuang YH, Liu YJ, Tang LL, Wang SM, Yan GJ, Liao LQ Tags: Hong Kong Med J Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | General Medicine | Hong Kong Health | Multidrug Resistance | Myeloma | Study